Medical Vaporizers with PZN & Aid Number: The Complete Guide to Certification, Insurance Coverage & Therapeutic Extraction

1. Introduction: Why the Certification of a Vaporizer Can Be a Matter of Life and Death

The legalization of medical cannabis in Germany in March 2017 was a paradigm shift – not only for pharmacy, but also for device technology. Suddenly, thousands of patients needed not only a prescription medication, but also a safe, reproducible, and certified delivery system. Smoking medical cannabis is contraindicated: the thermal pyrolysis of organic material generates benzene, polycyclic aromatic hydrocarbons (PAHs), and carcinogenic aldehydes – toxins that are unacceptable in a patient who may already be immunocompromised or oncologically damaged.

The technology industry's answer was the medical vaporizer – a device that separates active compounds exclusively through controlled heating (convection, conduction, or hybrid methods) from a solid or liquid matrix, without initiating combustion reactions. However, not every vaporizer that extracts active compounds is a medical vaporizer in the regulatory sense. The distinction lies in the CE certification under the MDR (Medical Device Regulation, EU 2017/745) as a Class IIa medical device, the assignment of a PZN by the Information Office for Medicinal Products (IFA), and listing in the Aid Directory (Hilfsmittelverzeichnis) of the Federal Association of Statutory Health Insurance Funds.

This guide illuminates the entire ecosystem: from the thermodynamics of the vaporization process, through the regulatory framework of certification, to the practical application process for insurance reimbursement. For further device recommendations, visit our Vaporizer Buying Guides & Extraction Tech category.

2. Technical Functionality: Thermodynamics, Active-Compound Release & Materials Science

2.1 Conduction vs. Convection

The fundamental physics of a vaporizer are based on two heat-transfer mechanisms:

• Conduction (conduction heat transfer): The heat source directly contacts the plant material. Thermal energy is transferred through molecular collision processes within the material. The disadvantage: uneven heating, hot spots on the contact surface, unavoidable local overheating, and a higher proportion of micro-pyrolytic decomposition products. Temperature gradients of up to 30 °C within a 0.15-g chamber are documented in the literature.
• Convection (convective heat transfer): Hot air flows through the material and heats it volumetrically. Heat transfer follows Newton's Law of Cooling: Q = h·A·(T_fluid – T_material). The flow velocity, air temperature, and specific surface area of the plant material (dependent on grind size) determine the extraction rate. The advantage: homogeneous temperature distribution, no hot spots, and noticeably cleaner vapor.
• Hybrid systems: The best medical devices combine both principles. The Storz & Bickel Mighty-Medic system uses a metallic fill-chamber element that pre-heats via conduction while the through-flowing hot air handles convective extraction. The result: fast heat-up time combined with clean active-compound release.

2.2 Boiling Points of Therapeutically Relevant Compounds

Precise temperature control in a medical vaporizer is therapeutically essential because different active compounds have different vaporization temperatures:

• CBN (Cannabinol): ~185 °C
• THC (Δ⁹-Tetrahydrocannabinol): ~157 °C
• CBD (Cannabidiol): ~160–180 °C
• THCA (Tetrahydrocannabinolic Acid): decarboxylates to THC from ~105 °C upward; fully vaporizes at ~185 °C
• Linalool (terpene): ~198 °C
• Myrcene (terpene): ~167 °C
• β-Caryophyllene (terpene, CB2 agonist): ~119 °C
• Limonene (terpene): ~176 °C
• α-Pinene (terpene): ~156 °C

A therapist aiming for a sedating effect can set the temperature to 190–200 °C to also extract the higher-boiling sesquiterpenes and CBN. For daytime anxiolytic effects without sedation, 160–175 °C are ideal windows. Medical devices such as the Mighty Medic offer step systems in 1 °C increments to precisely hit this therapeutic window.

2.3 Extraction Efficiency & Bioavailability

Studies (e.g., Hazekamp et al., Cannabinoids 2006; Pomahacova et al., Journal of Pharmaceutical Sciences 2009) demonstrate that the efficiency of vaporizers ranges from 60–85 % of the total cannabinoid content, depending on the device and temperature. The difference between devices is significant: simple conduction vaporizers often fall below 60 %, while high-quality hybrid convection devices such as the Mighty Medic extract at 80 %+ . The residual amount remains in the browned material (AVB – Already Vaped Bud), which can potentially be repurposed for topical or oral use.

Through inhalative uptake via a vaporizer, onset of effects occurs within 2–5 minutes (compared to 30–90 minutes with oral administration). The maximum plasma concentration (C_max) of THC after vaporization is reached at approximately 5–10 minutes, with an elimination half-life of 2–4 hours. For pain patients experiencing breakthrough pain, this pharmacokinetic profile is therapeutically superior.

2.4 Materials Science & Material Safety

Certified medical vaporizers must be toxicologically safe from a materials standpoint. This means:

• Vapor path: Isolated from the heating element, manufactured from medical-grade polypropylene (PP), polyetherimide (PEI), or stainless steel (V2A/1.4301). No silicone components in the vapor path, as siloxanes can become volatile above 200 °C.
• Heating element: Ceramic or metallic heating resistors with a constant resistance-temperature characteristic (PTC principle) to ensure self-regulation during temperature spikes.
• Battery: Lithium-ion cells (18650 or 21700) with protection circuits against overcharge, deep discharge, and short circuit. The BMS (Battery Management System) control in medical devices is redundantly implemented compared to consumer devices.

4. System & Model Comparison in Detail

4.1 Storz & Bickel – The Gold Standard of Medical Vaporizers

The Tuttlingen-based company Storz & Bickel, founded in 1996 by Markus Storz and Jürgen Bickel, is the only manufacturer worldwide holding an FDA 510(k) clearance, CE marking as a Class IIa medical device, and multiple patents in pharmaceutical vaporization technology. In 2018, the majority of the company was acquired by Canopy Growth (Canada), which accelerated the further development of the medical product line.

The Mighty Medic & Mighty+ Medic

The Mighty Medic is the medical variant of the consumer Mighty. The difference lies not in the basic architecture, but in the documentation, quality control, and regulatory classification: additional validation of temperature accuracy over the entire product lifespan, biocompatible material certificates for all vapor-path components, expanded risk assessment per ISO 14971, and a strict procedure and testing documentation system per ISO 13485.

The Mighty+ Medic introduces USB-C charging capability, an improved charging circuit, and a more energy-efficient heating element. Both devices utilize Superbooster mode: an automatic afterheat of +15 °C to extract the higher-boiling terpenes and cannabinoids at the end of a session. The hybrid heating chamber holds 0.15 g to 0.25 g of medical cannabis flower material and reaches the target temperature in approximately 60–90 seconds.

The Volcano Medic 2

The Volcano Medic 2 is the desktop counterpart. An external blower generates a precisely regulated hot-air flow (20–30 l/min) that heats the plant material in the fill chamber. The vapor is directed into a balloon bag – a system that has established itself as the gold standard in clinical studies because it enables dose-reproducible delivery over a defined period of time. Ideal for patients with limited manual dexterity or lung disease, as the vapor is cooled inside the balloon and inhaled without draw resistance. Temperature stability is ± 1 °C.

4.2 The Storz & Bickel Venty – Ambitious, but Not Yet Medical-Device Status

The Venty is technically a masterpiece: patented adjustable AirFlow regulator (10–20 l/min), extremely fast heat-up time under 30 seconds, and the most powerful battery-heating circuit in the product line. Nonetheless, as of the editorial review date, the Venty does not carry a CE mark as a medical device and is therefore not eligible for reimbursement through health insurance. Information about a possible certification in 2026 exists, but remains speculative at this time.

4.3 Tinymight 2 – Finnish Excellence, but Off-Label Therapeutic Use

The Tinymight 2 from Finland uses an on-demand heating system: the heater is only activated upon inhalation, enabling extremely high active-compound yields per draw while preserving the material. The convection chamber is optimized for 0.15 g, and temperature control is managed through 10 predefined stages without a digital display. The device is highly popular among experienced patients but, due to the lack of CE classification, is not an insurance-reimbursable device.

4.4 Arizer Solo III – The Glass-Chamber Solution

Arizer (Canada) relies on a fully isolated glass-chamber vapor path. The glass is inert, taste-neutral, and easy to clean. The Solo III offers dual-stem options and extremely long battery life. For patients who value flavor experience and material purity, the Arizer family is the first choice. However, it also lacks a medical-device certificate and insurance coverage eligibility.

4.5 DynaVap – Butane Vaporization Without Electronics

DynaVap devices utilize a bimetal temperature sensor: at approximately 185 °C, the device produces an audible "Click," signaling the optimal extraction temperature. No battery, no electronics, no reimport risk. However, operation with a butane torch requires a delicate touch – and uncontrolled overheating is possible. Though not medically certified, DynaVap is valued by pain patients as a backup device.

4.6 Ball Vapes – Desktop Vaporization for Maximum Extraction

Ball vapes are the newest desktop phenomenon: a single heating element loaded with quartz balls serving as thermal mass, inserted into a bong-like water-filtration system. Extraction efficiency surpasses all battery-powered devices – in under one minute, 0.5 g of medical cannabis is fully extracted. The temperature can be calibrated to the tenth of a degree, and the quartz beads ensure a consistent, slow release of volatiles throughout the session. For patients requiring high-dose, rapid-onset inhalation therapy – particularly those in palliative care or with acute oncological pain – ball vapes represent the current apex of desktop extraction technology.

5. The Regulatory Architecture: From CE Certification to Insurance Reimbursement

5.1 CE Marking under the MDR (EU 2017/745)

Since May 2021, the EU Medical Device Regulation (MDR) has been fully binding. Vaporizers marketed as medical devices must undergo conformity assessment by a Notified Body and receive a CE mark designating their risk classification. Most medical vaporizers fall under Class IIa (medium risk – devices intended for short-term use or used for diagnostic or therapeutic monitoring). Key requirements include:

• Comprehensive technical documentation per Annex II and Annex III of the MDR
• Clinical evaluation per Article 61, substantiating that the device achieves its intended purpose safely
• Post-market surveillance and periodic safety update reports (PSUR) for Class IIa devices
• Unique Device Identification (UDI) traceability
• Quality management system per ISO 13485:2016, certified by a Notified Body

For a vaporizer manufacturer, this means an investment of several hundred thousand euros and 12–24 months of development, testing, and documentation. This is precisely why so few devices currently hold medical-device certification – and why manufacturers like Storz & Bickel have a significant competitive advantage.

5.2 PZN (Pharmacy Central Number) – Identification in Wholesale Distribution

The PZN (Pharmazentralnummer) is a 8-digit product identifier administered by the Information Office for Medicinal Products (IFA). In the medical vaporizer context, the PZN is issued for products intended for pharmaceutical wholesale distribution – meaning they can be ordered and dispensed through the standard supply chain of pharmacies and medical-aid retailers. The PZN does not by itself constitute approval or insurance eligibility; it is a logistical identifier that confirms the product is part of the regulated supply system.

5.3 The Aid Number (Hilfsmittelnummer) – Gateway to Insurance Reimbursement

The aid number is registered in the Aid Directory (Hilfsmittelverzeichnis – HVM) maintained by the Federal Association of Statutory Health Insurance Funds (GKV-Spitzenverband). Unlike the PZN, the aid number is the sine qua non for cost reimbursement. Without an HVM entry, health insurance funds cannot legally approve a claim for a medical vaporizer as an aid. Key facts:

• The aid number typically begins with the digits indicating the aid category (e.g., 18 – Communication Aids, or 21 – Prosthetics / Orthotics, depending on classification).
• Applications for HVM registration are submitted by the manufacturer or marketing authorization holder to the GKV-Spitzenverband.
• Evaluation considers medical necessity, cost-effectiveness, and comparative therapeutic benefit over standard treatments.
• Once registered, the aid number appears on the product's invoice and is used by health insurance funds to process the reimbursement claim.

6. The Claims Process: Step-by-Step

Securing insurance reimbursement for a medical vaporizer and medical cannabis involves a structured four-stage process. While statutory health insurance funds are legally obligated under §31 Abs. 6 SGB V, each case must be individually justified. The four pillars:

1. Medication Plan (Medikationsplan): A physician-issued medication plan documenting the use of medical cannabis, the indications being treated, prior therapies that failed, and the rationale for vaporization as the preferred delivery route (vs. oral or sublingual administration).
2. Physician's Attestation (Arztattest): A formal statement from the treating physician confirming the medical indication, the recommended vaporizer model, and the expected therapeutic benefit. This document must reference the CE certification and aid number of the specified device.
3. Expert Medical Opinion (Ärztliches Gutachten): In many cases, health insurance funds require an independent expert opinion – particularly when the treatment deviates from standard therapy. This is often provided by an approved private expert (Vertragsgutachter) of the